Hi All,
In the past there has been talk about what Pharmaust could expect to receive following a canine licensing deal with a major. Below is a recent agreement with another Oz small cap. In this case they are paying the owner of the drug, hence the payable costs after commencing Phase 1 and 2 etc.
Add to this an upfront fee, normally reflecting costs associated with development to get this far. [Apprpx 20 Million +] and an ongoing royalty as described by RA in the recent Q & A. [15 Million per annum]Dosing of fifth patient in Phase IDevelopment US$0.35m
Dosing of first patient in Phase II DevelopmentUS$0.75m
Dosing of the first patient in Phase III Development US$2m
Receipt of the first Orphan Drug Designation Regulatory US$1m
Marketing approval in the United States Regulatory US$6m
Marketing approval in Europe Regulatory US$6m
Marketing approval in each of the first five jurisdictions other than the United States and Europe Regulatory US$1m (US$5m total)
Upon net sales of US$250m in a year Commercial US$18.75m
Upon net sales of US$500m in a year Commercial US$35.5m
Hence the the advantage of getting a Canine Treatment up first, this would allow Pharmaust to spend up and accelerate the Human applications. I know there are probably other avenues available, but this is the closest one I can find to our situation.
Happy to see other / conflicting ideas, I can be swayed by a more informed view.
Pete
- Forums
- ASX - By Stock
- Covi-Pantel . NZ Trader Release
Hi All, In the past there has been talk about what Pharmaust...
-
- There are more pages in this discussion • 141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 140000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 537419 | 0.170 |
5 | 157060 | 0.165 |
9 | 476304 | 0.160 |
6 | 336734 | 0.155 |
8 | 225333 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 140000 | 3 |
0.185 | 427553 | 5 |
0.190 | 720215 | 6 |
0.195 | 752882 | 12 |
0.200 | 297726 | 10 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |